BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 85487)

  • 1. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative cell-mediated immune status of patients with malignant glial tumors.
    Sheikh KM; Apuzzo ML; Weiss MH
    Neurol Res; 1979; 1(2):133-45. PubMed ID: 233266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpesvirus type 1 serum antibodies and brain tumors in humans.
    Hadfield MG; Murray BK; Thomson TA; Young HF
    Clin Neuropathol; 1984; 3(2):68-71. PubMed ID: 6325061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular immunity in human brain tumours (author's transl)].
    Böker DK
    Neurochirurgia (Stuttg); 1980 Nov; 23(6):229-34. PubMed ID: 7442895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterogenous immune reactivity in brain tumors: results of cellular immunity in relation to brain tissue antigens].
    Meyer-Rienecker HJ; Jenssen HL; Mix E
    Fortschr Neurol Psychiatr; 1985 Oct; 53(10):363-9. PubMed ID: 2415433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 9. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autosensitization of neurosurgical cases by normal brain tissue antigens (author's transl)].
    Oda Y; Tokuriki Y; Takeuchi J; Handa H
    No Shinkei Geka; 1979 Oct; 7(10):953-9. PubMed ID: 392328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic lectin receptors of nervous system tumors. Study of gliomas, neural crest tumors, and meningiomas in vitro using phytohemagglutinin and concanavalin A.
    Liwnicz BH
    J Neuropathol Exp Neurol; 1982 May; 41(3):281-97. PubMed ID: 6281395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunology: a neurosurgical perspective. II. The immunology of glial neoplasms.
    Apuzzo ML
    Bull Los Angeles Neurol Soc; 1976 Oct; 41(4):176-83. PubMed ID: 74264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum acute-phase proteins and immunoglobulins in patients with gliomas.
    Weiss JF; Morantz RA; Bradley WP; Chretien PB
    Cancer Res; 1979 Feb; 39(2 Pt 1):542-4. PubMed ID: 83910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test.
    Kalafut F; Hung PM; Novotná L; Grófová M
    Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The features of the brain immune system in brain neoplasms].
    Starchenko AA; Khil'ko VA; Komarets SA; Shulev IuA; Ivanteeva EP; Bikmullin VN; Prilukova TI
    Zh Vopr Neirokhir Im N N Burdenko; 2002; (4):22-6; discussion 26-7. PubMed ID: 12608143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.